| Dr Bethany A Karwoski, MD | |
|
111 Michigan Ave Nw, Washington, DC 20010-2916 | |
| (202) 476-5000 | |
| Not Available |
| Full Name | Dr Bethany A Karwoski |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 111 Michigan Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033385646 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD039536 (District Of Columbia) | Primary |
| 207W00000X | Ophthalmology | 0101252707 (Virginia) | Secondary |
| Entity Name | Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
Until now, we have not had any specific treatment for the often fatal effects of heat stroke.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Artificial Intelligence (AI) is increasingly being used in medicine to support human expertise. However, the potential of these applications and the risks inherent in the interaction between human and artificial intelligence has not yet been thoroughly researched.
A massive and important new study published on the preprint server medRxiv* in July 2020 sets out a comprehensive picture of the COVID-19 outbreak in Catalonia, Spain. It fills in a void in the current research, with its grand scale and detailed analysis.
› Verified 1 days ago
| Entity Name | Eye Consultants Of Northern Virginia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952358020 PECOS PAC ID: 5294715827 Enrollment ID: O20040920000233 |
News Archive
Until now, we have not had any specific treatment for the often fatal effects of heat stroke.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Artificial Intelligence (AI) is increasingly being used in medicine to support human expertise. However, the potential of these applications and the risks inherent in the interaction between human and artificial intelligence has not yet been thoroughly researched.
A massive and important new study published on the preprint server medRxiv* in July 2020 sets out a comprehensive picture of the COVID-19 outbreak in Catalonia, Spain. It fills in a void in the current research, with its grand scale and detailed analysis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bethany A Karwoski, MD Po Box 37215, Baltimore, MD 21297-3215 Ph: () - | Dr Bethany A Karwoski, MD 111 Michigan Ave Nw, Washington, DC 20010-2916 Ph: (202) 476-5000 |
News Archive
Until now, we have not had any specific treatment for the often fatal effects of heat stroke.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Artificial Intelligence (AI) is increasingly being used in medicine to support human expertise. However, the potential of these applications and the risks inherent in the interaction between human and artificial intelligence has not yet been thoroughly researched.
A massive and important new study published on the preprint server medRxiv* in July 2020 sets out a comprehensive picture of the COVID-19 outbreak in Catalonia, Spain. It fills in a void in the current research, with its grand scale and detailed analysis.
› Verified 1 days ago
Dr. Saima M Qureshi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-6100 | |
Melanie J Buttross, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 21, Washington, DC 20016 Phone: 202-686-6700 Fax: 202-537-1442 | |
Dr. Bilal Khan Yousufzai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Dept Of Ophthalmology, Washington, DC 20010 Phone: 202-877-5658 Fax: 202-877-7743 | |
Dr. Marc Jay Holzman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2021 K St Nw, Suite 416, Washington, DC 20006 Phone: 202-296-1333 Fax: 202-296-9357 | |
Kelly Hutcheson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-3015 | |
Dr. Reginald Dacosta Barnes Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2112 F St Nw Ste 802, Washington, DC 20037 Phone: 202-331-1757 Fax: 202-331-1757 |